vs
普立万（AVNT）与Healthpeak Properties（DOC）财务数据对比。点击上方公司名可切换其他公司
普立万的季度营收约是Healthpeak Properties的1.1倍（$760.6M vs $719.4M），Healthpeak Properties净利率更高（73.2% vs 2.2%，领先71.0%），Healthpeak Properties同比增速更快（3.1% vs 1.9%），Healthpeak Properties自由现金流更多（$357.0M vs $125.4M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs -4.2%）
普立万公司是一家全球性材料解决方案供应商，总部位于美国俄亥俄州埃文湖，全球员工约9000人。主营产品涵盖色母粒、先进复合材料、功能添加剂以及工程材料，为多行业客户提供定制化的材料相关技术支持与解决方案。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
AVNT vs DOC — 直观对比
营收规模更大
AVNT
是对方的1.1倍
$719.4M
营收增速更快
DOC
高出1.2%
1.9%
净利率更高
DOC
高出71.0%
2.2%
自由现金流更多
DOC
多$231.6M
$125.4M
两年增速更快
DOC
近两年复合增速
-4.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $760.6M | $719.4M |
| 净利润 | $16.9M | $114.0M |
| 毛利率 | 30.2% | — |
| 营业利润率 | 5.2% | 17.4% |
| 净利率 | 2.2% | 73.2% |
| 营收同比 | 1.9% | 3.1% |
| 净利润同比 | -65.0% | 2406.4% |
| 每股收益（稀释后） | $0.18 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVNTDOC
| Q4 25 | $760.6M | $719.4M | ||
| Q3 25 | $806.5M | $705.9M | ||
| Q2 25 | $866.5M | $694.3M | ||
| Q1 25 | $826.6M | $702.9M | ||
| Q4 24 | $746.5M | $698.0M | ||
| Q3 24 | $815.2M | $700.4M | ||
| Q2 24 | $849.7M | $695.5M | ||
| Q1 24 | $829.0M | $606.6M |
净利润AVNTDOC
| Q4 25 | $16.9M | $114.0M | ||
| Q3 25 | $32.6M | $-117.1M | ||
| Q2 25 | $52.6M | $31.7M | ||
| Q1 25 | $-20.2M | $42.8M | ||
| Q4 24 | $48.3M | $4.5M | ||
| Q3 24 | $38.2M | $85.9M | ||
| Q2 24 | $33.6M | $146.0M | ||
| Q1 24 | $49.4M | $6.7M |
毛利率AVNTDOC
| Q4 25 | 30.2% | — | ||
| Q3 25 | 30.4% | 58.6% | ||
| Q2 25 | 32.1% | 60.2% | ||
| Q1 25 | 31.8% | 61.1% | ||
| Q4 24 | 34.8% | 60.3% | ||
| Q3 24 | 32.1% | 60.0% | ||
| Q2 24 | 30.3% | 60.6% | ||
| Q1 24 | 33.6% | 59.8% |
营业利润率AVNTDOC
| Q4 25 | 5.2% | 17.4% | ||
| Q3 25 | 8.3% | 9.2% | ||
| Q2 25 | 11.1% | 5.7% | ||
| Q1 25 | 0.1% | 7.7% | ||
| Q4 24 | 11.5% | -2.2% | ||
| Q3 24 | 9.5% | 14.1% | ||
| Q2 24 | 8.5% | 22.3% | ||
| Q1 24 | 11.3% | 3.7% |
净利率AVNTDOC
| Q4 25 | 2.2% | 73.2% | ||
| Q3 25 | 4.0% | -16.6% | ||
| Q2 25 | 6.1% | 4.6% | ||
| Q1 25 | -2.4% | 6.1% | ||
| Q4 24 | 6.5% | 0.7% | ||
| Q3 24 | 4.7% | 12.3% | ||
| Q2 24 | 4.0% | 21.0% | ||
| Q1 24 | 6.0% | 1.1% |
每股收益（稀释后）AVNTDOC
| Q4 25 | $0.18 | $0.16 | ||
| Q3 25 | $0.36 | $-0.17 | ||
| Q2 25 | $0.57 | $0.05 | ||
| Q1 25 | $-0.22 | $0.06 | ||
| Q4 24 | $0.53 | $0.02 | ||
| Q3 24 | $0.41 | $0.12 | ||
| Q2 24 | $0.36 | $0.21 | ||
| Q1 24 | $0.54 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $467.5M |
| 总债务越低越好 | $1.9B | $9.8B |
| 股东权益账面价值 | $2.4B | $7.5B |
| 总资产 | $6.0B | $20.3B |
| 负债/权益比越低杠杆越低 | 0.81× | 1.31× |
8季度趋势，按日历期对齐
现金及短期投资AVNTDOC
| Q4 25 | — | $467.5M | ||
| Q3 25 | — | $91.0M | ||
| Q2 25 | — | $89.4M | ||
| Q1 25 | — | $70.6M | ||
| Q4 24 | — | $119.8M | ||
| Q3 24 | — | $180.4M | ||
| Q2 24 | — | $106.9M | ||
| Q1 24 | — | $101.8M |
总债务AVNTDOC
| Q4 25 | $1.9B | $9.8B | ||
| Q3 25 | $2.0B | $9.1B | ||
| Q2 25 | $2.0B | $9.0B | ||
| Q1 25 | $2.1B | $8.9B | ||
| Q4 24 | $2.1B | $8.7B | ||
| Q3 24 | $2.1B | $8.6B | ||
| Q2 24 | $2.1B | $8.6B | ||
| Q1 24 | $2.1B | $8.8B |
股东权益AVNTDOC
| Q4 25 | $2.4B | $7.5B | ||
| Q3 25 | $2.4B | $7.6B | ||
| Q2 25 | $2.4B | $7.9B | ||
| Q1 25 | $2.3B | $8.2B | ||
| Q4 24 | $2.3B | $8.4B | ||
| Q3 24 | $2.4B | $8.6B | ||
| Q2 24 | $2.3B | $8.8B | ||
| Q1 24 | $2.3B | $8.9B |
总资产AVNTDOC
| Q4 25 | $6.0B | $20.3B | ||
| Q3 25 | $6.1B | $19.6B | ||
| Q2 25 | $6.1B | $19.8B | ||
| Q1 25 | $5.8B | $19.8B | ||
| Q4 24 | $5.8B | $19.9B | ||
| Q3 24 | $6.0B | $20.0B | ||
| Q2 24 | $5.9B | $20.2B | ||
| Q1 24 | $5.9B | $20.5B |
负债/权益比AVNTDOC
| Q4 25 | 0.81× | 1.31× | ||
| Q3 25 | 0.83× | 1.20× | ||
| Q2 25 | 0.86× | 1.14× | ||
| Q1 25 | 0.90× | 1.08× | ||
| Q4 24 | 0.89× | 1.04× | ||
| Q3 24 | 0.88× | 1.00× | ||
| Q2 24 | 0.90× | 0.98× | ||
| Q1 24 | 0.90× | 0.99× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $167.8M | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $125.4M | $357.0M |
| 自由现金流率自由现金流/营收 | 16.5% | 49.6% |
| 资本支出强度资本支出/营收 | 5.6% | 124.4% |
| 现金转化率经营现金流/净利润 | 9.93× | 10.99× |
| 过去12个月自由现金流最近4个季度 | $195.0M | — |
8季度趋势，按日历期对齐
经营现金流AVNTDOC
| Q4 25 | $167.8M | $1.3B | ||
| Q3 25 | $72.1M | $315.0M | ||
| Q2 25 | $112.8M | $363.5M | ||
| Q1 25 | $-51.1M | $279.4M | ||
| Q4 24 | $122.6M | $1.1B | ||
| Q3 24 | $71.1M | $318.2M | ||
| Q2 24 | $105.9M | $316.2M | ||
| Q1 24 | $-42.8M | $152.6M |
自由现金流AVNTDOC
| Q4 25 | $125.4M | $357.0M | ||
| Q3 25 | $47.4M | — | ||
| Q2 25 | $85.8M | — | ||
| Q1 25 | $-63.6M | — | ||
| Q4 24 | $81.5M | $333.7M | ||
| Q3 24 | $46.1M | — | ||
| Q2 24 | $74.5M | — | ||
| Q1 24 | $-67.2M | — |
自由现金流率AVNTDOC
| Q4 25 | 16.5% | 49.6% | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 9.9% | — | ||
| Q1 25 | -7.7% | — | ||
| Q4 24 | 10.9% | 47.8% | ||
| Q3 24 | 5.7% | — | ||
| Q2 24 | 8.8% | — | ||
| Q1 24 | -8.1% | — |
资本支出强度AVNTDOC
| Q4 25 | 5.6% | 124.4% | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 5.5% | 105.6% | ||
| Q3 24 | 3.1% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | 2.9% | — |
现金转化率AVNTDOC
| Q4 25 | 9.93× | 10.99× | ||
| Q3 25 | 2.21× | — | ||
| Q2 25 | 2.14× | 11.48× | ||
| Q1 25 | — | 6.52× | ||
| Q4 24 | 2.54× | 235.43× | ||
| Q3 24 | 1.86× | 3.71× | ||
| Q2 24 | 3.15× | 2.17× | ||
| Q1 24 | -0.87× | 22.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVNT
| Color Additives And Inks | $466.0M | 61% |
| Specialty Engineered Materials | $295.5M | 39% |
DOC
暂无分部数据
